PE20060478A1 - Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion - Google Patents

Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion

Info

Publication number
PE20060478A1
PE20060478A1 PE2005000727A PE2005000727A PE20060478A1 PE 20060478 A1 PE20060478 A1 PE 20060478A1 PE 2005000727 A PE2005000727 A PE 2005000727A PE 2005000727 A PE2005000727 A PE 2005000727A PE 20060478 A1 PE20060478 A1 PE 20060478A1
Authority
PE
Peru
Prior art keywords
tissue
trifluorometoxyphenoxybenzene
sulphonic acids
refers
formula
Prior art date
Application number
PE2005000727A
Other languages
English (en)
Inventor
Manfred Schudok
Armin Hofmeister
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PE20060478A1 publication Critical patent/PE20060478A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Abstract

SE REFIERE A COMPUESTOS DE ACIDOS 4-TRIFLUOROMETOXIFENOXIBENCENO-4'-SULFONICOS DE FORMULA (I), EN DONDE X ES OH O -NH-OH; A ES UN RADICAL DE FORMULA (II), EN DONDE R4 ES UN ENLACE COVALENTE AL S DE (I); R1, R2 O R3 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6), -C(O)-O-R8, O-R8, ENTRE OTROS; O R1 Y R2 JUNTOS AL CARBONO AL QUE ESTAN UNIDOS FORMAN ARILO(C6-C14), Het DE 5 A 7 MIEMBROS, INDOLILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON G, TAL COMO FENILO, TETRAHIDROFURANILO O CICLOHEXILO. SON PREFERIDOS: 2-[4-(4-TRIFLUOROMETOXIFENOXI)BENCENOSULFONIL]-1,2,3,4-TETRAHIDRO-ISOQUINOLIN-1-HIDROXI-CARBOXAMIDA, ACIDO 5-[4-(4-TRIFLUOROMETOXIFENOXI)BENCENOSULFONIL]OCTAHIDROFURO[3,2-c]PIRIDIN-4-CARBOXILICO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE LA METALOPROTEINASA DE LA MATRIZ (MMP), POR LO QUE SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS ARTICULARES DEGENERATIVOS COMO OSTEOARTROSIS, ESPONDILOSIS, TRANSTORNOS DEL TEJIDO CONJUNTIVO Y EN EL TRATAMIENTO DE INFLAMACIONES, ULCERAS, ATEROSCLEROSIS
PE2005000727A 2004-06-30 2005-06-23 Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion PE20060478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004031620A DE102004031620A1 (de) 2004-06-30 2004-06-30 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
PE20060478A1 true PE20060478A1 (es) 2006-06-22

Family

ID=34970397

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000727A PE20060478A1 (es) 2004-06-30 2005-06-23 Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion

Country Status (21)

Country Link
US (2) US20070155778A1 (es)
EP (1) EP1763515B1 (es)
JP (1) JP4871273B2 (es)
KR (1) KR20070026662A (es)
CN (1) CN101035764A (es)
AR (1) AR049557A1 (es)
AT (1) ATE388940T1 (es)
AU (1) AU2005259634A1 (es)
BR (1) BRPI0512656A (es)
CA (1) CA2572126A1 (es)
DE (2) DE102004031620A1 (es)
DK (1) DK1763515T3 (es)
ES (1) ES2299039T3 (es)
IL (1) IL179975A0 (es)
MX (1) MXPA06014189A (es)
MY (1) MY139236A (es)
PE (1) PE20060478A1 (es)
PT (1) PT1763515E (es)
TW (1) TW200612943A (es)
UY (1) UY28994A1 (es)
WO (1) WO2006002764A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10344936A1 (de) * 2003-09-27 2005-04-21 Aventis Pharma Gmbh Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
BRPI0812058B1 (pt) 2007-05-31 2017-03-28 Koninl Philips Electronics Nv sistema de ferro de passar

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0861236T4 (da) * 1995-11-13 2006-12-18 Sanofi Aventis Deutschland Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer
WO1998008815A1 (en) * 1996-08-28 1998-03-05 The Procter & Gamble Company Substituted cyclic amine metalloprotease inhibitors
WO1998050348A1 (en) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6294573B1 (en) * 1997-08-06 2001-09-25 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6750228B1 (en) * 1997-11-14 2004-06-15 Pharmacia Corporation Aromatic sulfone hydroxamic acid metalloprotease inhibitor
AU756150C (en) * 1997-11-14 2004-03-04 G.D. Searle & Co. Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US20010039287A1 (en) * 1997-11-14 2001-11-08 Thomas E Barta Aromatic sulfone hydroxamic acid metalloprotease inhibitor
DE10344936A1 (de) * 2003-09-27 2005-04-21 Aventis Pharma Gmbh Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen
DE102004031850A1 (de) * 2004-06-30 2006-01-26 Sanofi-Aventis Deutschland Gmbh Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
DE102004031620A1 (de) 2006-02-02
JP2008504316A (ja) 2008-02-14
ES2299039T3 (es) 2008-05-16
DE502005003219D1 (de) 2008-04-24
MY139236A (en) 2009-09-30
AR049557A1 (es) 2006-08-16
AU2005259634A1 (en) 2006-01-12
IL179975A0 (en) 2007-05-15
BRPI0512656A (pt) 2008-04-01
KR20070026662A (ko) 2007-03-08
ATE388940T1 (de) 2008-03-15
MXPA06014189A (es) 2007-03-12
PT1763515E (pt) 2008-04-07
TW200612943A (en) 2006-05-01
CA2572126A1 (en) 2006-01-12
CN101035764A (zh) 2007-09-12
WO2006002764A1 (de) 2006-01-12
EP1763515B1 (de) 2008-03-12
US20100099663A1 (en) 2010-04-22
DK1763515T3 (da) 2008-06-16
EP1763515A1 (de) 2007-03-21
JP4871273B2 (ja) 2012-02-08
UY28994A1 (es) 2006-01-31
US20070155778A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
UY28877A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida y composiciones
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
EA201071232A1 (ru) Триазины как ингибиторы киназы pi3 и mtor
ECSP088965A (es) Derivados de 2-tioxantina que actúan como inhibidores de la mpo
ECSP088765A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
PE20091712A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
MY154595A (en) Benzimidazole modulators of vr1
BRPI0718700B8 (pt) Heterodímeros de ácido glutâmico, e kit
NI201100081A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa - iv para el tratamiento o prevención de diabetes.
PE20061073A1 (es) Compuestos derivados de piperidinilamida como agentes inhibidores de quinasas
TN2014000115A1 (fr) Derives de pyrrolopyrimidines et de purines
EA201170607A1 (ru) Акриламидопроизводные, применимые как ингибиторы перехода митохондриальной проницаемости
AR067673A1 (es) Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas.
PE20040450A1 (es) Heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida como inhibidores de metaloproteinasa
GB0517191D0 (en) Compounds
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
EA201170780A1 (ru) Урацильные циклопропилнуклеотиды
AR067105A1 (es) Moleculas pequenas que contienen boro
MA39043A1 (fr) Dérivés de purine substitués en positions 2 et 6, et leur utilisation dans le traitement des désordres prolifératifs
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
TW200716531A (en) Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia
PE20070179A1 (es) Derivados de purina como agonistas del receptor de adenosina a2
CL2011002859A1 (es) Compuestos espironucleosidos, inhibidores del virus vhc; composicion farmaceutica de dichos compuestos; uso del compuesto para tratar la hepatitis c.
BRPI0711310B8 (pt) composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal